Featured conditions Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
Featured conditions
Results filtered:Study status: Closed for Enrollment
The purpose of this study is to explore the level of similarity in pharmacodynamic responses to GUCY2C agonists in organoids prepared from rectal biopsies from all healthy subjects, independent of changes in their bowel movements induced by oral administration of 27 mg/day of dolcanatide for 7 days.